Review



pe cd19 antibody  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Miltenyi Biotec pe cd19 antibody
    (A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, <t>CD19,</t> CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).
    Pe Cd19 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 316 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe cd19 antibody/product/Miltenyi Biotec
    Average 95 stars, based on 316 article reviews
    pe cd19 antibody - by Bioz Stars, 2026-03
    95/100 stars

    Images

    1) Product Images from "Nuclei Isolation Methods on Frozen Clotted Blood Samples"

    Article Title: Nuclei Isolation Methods on Frozen Clotted Blood Samples

    Journal: Bio-protocol

    doi: 10.21769/BioProtoc.5573

    (A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, CD19, CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).
    Figure Legend Snippet: (A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, CD19, CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).

    Techniques Used: Isolation, Staining, Marker

    Read depths are generous at the start site of beta actin, indicative of an accessible chromatin region for both CD3+ T cells and CD19+ B cells. For CD3E, an accessible chromatin region is present in T cells with more read depth, but not in B cells. CD79A is a known marker in B cells and has generous read depths for B cells but is absent in T cells.
    Figure Legend Snippet: Read depths are generous at the start site of beta actin, indicative of an accessible chromatin region for both CD3+ T cells and CD19+ B cells. For CD3E, an accessible chromatin region is present in T cells with more read depth, but not in B cells. CD79A is a known marker in B cells and has generous read depths for B cells but is absent in T cells.

    Techniques Used: Marker



    Similar Products

    pe conjugated antibody  (Bioss)
    94
    Bioss pe conjugated antibody
    Pe Conjugated Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe conjugated antibody/product/Bioss
    Average 94 stars, based on 1 article reviews
    pe conjugated antibody - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    pe cd19 antibody  (Miltenyi Biotec)
    95
    Miltenyi Biotec pe cd19 antibody
    (A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, <t>CD19,</t> CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).
    Pe Cd19 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe cd19 antibody/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    pe cd19 antibody - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier
    cd19 polyclonal antibody  (Bioss)
    94
    Bioss cd19 polyclonal antibody
    (A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, <t>CD19,</t> CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).
    Cd19 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd19 polyclonal antibody/product/Bioss
    Average 94 stars, based on 1 article reviews
    cd19 polyclonal antibody - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    cd3 cd19 antigen pe a ntigen apc  (Miltenyi Biotec)
    94
    Miltenyi Biotec cd3 cd19 antigen pe a ntigen apc
    (A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, <t>CD19,</t> CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).
    Cd3 Cd19 Antigen Pe A Ntigen Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd3 cd19 antigen pe a ntigen apc/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    cd3 cd19 antigen pe a ntigen apc - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    pe vio770  (Miltenyi Biotec)
    95
    Miltenyi Biotec pe vio770
    (A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, <t>CD19,</t> CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).
    Pe Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe vio770/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    pe vio770 - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier
    bergisch gladbach  (Miltenyi Biotec)
    95
    Miltenyi Biotec bergisch gladbach
    (A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, <t>CD19,</t> CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).
    Bergisch Gladbach, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bergisch gladbach/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    bergisch gladbach - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier
    recombinant monoclonal anti mouse cd19 pevio770 reafinity conjugated miltenyi biotec  (Miltenyi Biotec)
    95
    Miltenyi Biotec recombinant monoclonal anti mouse cd19 pevio770 reafinity conjugated miltenyi biotec
    (A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, <t>CD19,</t> CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).
    Recombinant Monoclonal Anti Mouse Cd19 Pevio770 Reafinity Conjugated Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant monoclonal anti mouse cd19 pevio770 reafinity conjugated miltenyi biotec/product/Miltenyi Biotec
    Average 95 stars, based on 1 article reviews
    recombinant monoclonal anti mouse cd19 pevio770 reafinity conjugated miltenyi biotec - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier
    anti cd19 car fmc63 idiotype antibody  (Miltenyi Biotec)
    94
    Miltenyi Biotec anti cd19 car fmc63 idiotype antibody
    (A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, <t>CD19,</t> CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).
    Anti Cd19 Car Fmc63 Idiotype Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd19 car fmc63 idiotype antibody/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    anti cd19 car fmc63 idiotype antibody - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, CD19, CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).

    Journal: Bio-protocol

    Article Title: Nuclei Isolation Methods on Frozen Clotted Blood Samples

    doi: 10.21769/BioProtoc.5573

    Figure Lengend Snippet: (A) Gating strategy for sorting singlets of B and T cells. (B) Sorted counts. Leukocytes were isolated from previously frozen blood clots and dissociated by following section A of this protocol. Cells were stained with an antibody panel targeting CD3, CD19, CD11b, and CD11c. Viability marker was not used due to interest in nuclei from subpopulations of non-viable leukocytes. After doublet exclusion and gating on height and area of cells, T-cell subsets were identified as CD3+ populations. B-cell subsets were identified as CD19+ populations. CD11b and CD11c were used to exclude monocytes. Single-stain controls were used for compensation. During this sort, we successfully sorted 57,894 T cells and 24,648 B cells. The full report is available in Supplementary material (Report S1).

    Article Snippet: Flow cytometry antibodies (only applicable if flow sorting) a. FITC CD3 antibody (Miltenyi Biotec, catalog number: 130-113-700) b. PE CD19 antibody (Miltenyi Biotec, catalog number: 130-114-172) c. VioBlue CD11B (Miltenyi Biotec, catalog number: 130-110-616) d. APC CD11C (Miltenyi Biotec, catalog number: 130-114-110) e. Other antibodies (optional): Add other suitable antibodies to tailor the cell population of interest 3.

    Techniques: Isolation, Staining, Marker

    Read depths are generous at the start site of beta actin, indicative of an accessible chromatin region for both CD3+ T cells and CD19+ B cells. For CD3E, an accessible chromatin region is present in T cells with more read depth, but not in B cells. CD79A is a known marker in B cells and has generous read depths for B cells but is absent in T cells.

    Journal: Bio-protocol

    Article Title: Nuclei Isolation Methods on Frozen Clotted Blood Samples

    doi: 10.21769/BioProtoc.5573

    Figure Lengend Snippet: Read depths are generous at the start site of beta actin, indicative of an accessible chromatin region for both CD3+ T cells and CD19+ B cells. For CD3E, an accessible chromatin region is present in T cells with more read depth, but not in B cells. CD79A is a known marker in B cells and has generous read depths for B cells but is absent in T cells.

    Article Snippet: Flow cytometry antibodies (only applicable if flow sorting) a. FITC CD3 antibody (Miltenyi Biotec, catalog number: 130-113-700) b. PE CD19 antibody (Miltenyi Biotec, catalog number: 130-114-172) c. VioBlue CD11B (Miltenyi Biotec, catalog number: 130-110-616) d. APC CD11C (Miltenyi Biotec, catalog number: 130-114-110) e. Other antibodies (optional): Add other suitable antibodies to tailor the cell population of interest 3.

    Techniques: Marker